Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;13(1):2396869.
doi: 10.1080/22221751.2024.2396869. Epub 2024 Sep 8.

Response to the letter to the editor: Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris

Affiliations

Response to the letter to the editor: Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris

Ehab A Salama et al. Emerg Microbes Infect. 2024 Dec.
No abstract available

PubMed Disclaimer

References

    1. Zhu M, Wang H, Zhang Y, et al. Letter to the editor: lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug–resistant Candida auris. Emerg Microbes Infect. 2024;13(1). doi:10.1080/22221751.2024.2356144 - DOI
    1. Salama EA, Elgammal Y, Wijeratne A, et al. . Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris. Emerg Microbes Infect. 2024;13:2322649. doi:10.1080/22221751.2024.2322649 - DOI - PMC - PubMed
    1. Rybniker J, Vocat A, Sala C, et al. . Lansoprazole is an antituberculous prodrug targeting cytochrome bc1. Nat Commun. 2015;6:7659. doi:10.1038/ncomms8659 - DOI - PMC - PubMed
    1. Gao L, Xia X, Gong X, et al. . In vitro interactions of proton pump inhibitors and azoles against pathogenic fungi. Front Cell Infect Microbiol. 2024;14:1296151. doi:10.3389/fcimb.2024.1296151 - DOI - PMC - PubMed
    1. Yi M, Niu M, Zhang J, et al. . Combine and conquer: manganese synergizing anti-TGF-beta/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers. J Hematol Oncol. 2021;14:146. doi:10.1186/s13045-021-01155-6 - DOI - PMC - PubMed

LinkOut - more resources